An Open Label, Expanded Access Study of Melphalan Chemosaturation With the Delcath System in Patients With Ocular and Cutaneous Melanoma Metastatic to the Liver

Trial Profile

An Open Label, Expanded Access Study of Melphalan Chemosaturation With the Delcath System in Patients With Ocular and Cutaneous Melanoma Metastatic to the Liver

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 22 Oct 2013

At a glance

  • Drugs Melphalan (Primary)
  • Indications Liver metastases; Malignant melanoma; Uveal melanoma
  • Focus Expanded access; Therapeutic Use
  • Most Recent Events

    • 19 Dec 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top